Premarket today TRVN has dropped almost 70% off news that the FDA believes their drug Oliceridine has high abuse potential. With ACRX's ADCOM this week too I can understand the hesitation to … [Read more...] about ACRX Stay the course
Swing Trades
SWING ALERT
AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) Swing Thesis ACRX traded last around $2.90 and has entered oversold territory. It has a FDA advisory committee meeting (ADCOM) scheduled for 10/12/2018 and a … [Read more...] about SWING ALERT
Swing Trading a Biotech Stock
Overview Swing Trading is a trading strategy that involves buying a stock at a lower price and selling it at a higher price over a short period of time. Return on investment targets ranges from … [Read more...] about Swing Trading a Biotech Stock
GALT is Strong Buy: Oversold and Cancer Catalyst Imminent
Galectin Therapeutics (NASDAQ: GALT $3.80) GALT is our number 1 stock pick for August, 2018. After a fundamental analysis we conclude the scientific data is credible & compelling, GALT is … [Read more...] about GALT is Strong Buy: Oversold and Cancer Catalyst Imminent
